Kynam Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Kynam Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-235,176	Closed	-$2.9M	–	30
2023 Q3	$2.9M	Sell	235,176 -1,069,156	-82%	-$10.9M	0.48%	24
2023 Q2	$11.8M	Sell	1,304,332 -707,521	-35%	-$4.27M	1.62%	17
2023 Q1	$6.98M	Sell	2,011,853 -13,381	-0.7%	-$54.6K	0.9%	21
2022 Q4	$4.96M	Buy	2,025,234 +625,601	+45%	+$1.82M	0.76%	20
2022 Q3	$3.86M	Buy	1,399,633 +1,150,404	+462%	+$4.88M	0.81%	25
2022 Q2	$1.01M	Sell	249,229 -31,598	-11%	-$100K	0.26%	27
2022 Q1	$1.2M	Sell	280,827 -12,972	-4%	-$71.5K	0.39%	28
2021 Q4	$2.75M	Buy	+293,799	New	+$6.09M	1.47%	19

Other funds holding OLMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kynam Capital Management's OLMA Position: Q4 2023 in Review

Kynam Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q4 2023, closing a stake of 235,176 shares — an estimated $2.9M sold.

Kynam Capital Management first reported a position in OLMA in Q4 2021 and held it in 8 quarters. The position peaked at $11.8M in Q2 2023. 113 funds tracked by Wall St. Rank hold OLMA as of Q4 2023.

Kynam Capital Management reported no remaining Olema Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Kynam Capital Management sold 235,176 Olema Pharmaceuticals shares in Q4 2023, an estimated $2.9M.
Kynam Capital Management first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 8 quarters.
Kynam Capital Management's Olema Pharmaceuticals position peaked at $11.8M in Q2 2023.
113 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2023.

Based on Kynam Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.